(Q58102530)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

title

Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Susan Evans-Axelsson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

author name string

Liu Wei

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Wolfgang P Fendler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Andreea D Stuparu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Roger Slavik

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Christine E Mona

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Jeremie Calais

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Matthew Rettig

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Robert E Reiter

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Ken Herrmann

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Caius G Radu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Johannes Czernin

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Matthias Eiber

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

language of work or name

English

0 references

publication date

29 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

page(s)

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

1 May 2020

copyright license

start time

29 October 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer

1 reference

12 December 2020

Minimally invasive assessment of tumor angiogenesis by fine needle aspiration and flow cytometry

1 reference

12 December 2020

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer

1 reference

12 December 2020

Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen

1 reference

12 December 2020

Increased survival with enzalutamide in prostate cancer after chemotherapy

1 reference

12 December 2020

Evaluation of the Genisys4, a bench-top preclinical PET scanner

1 reference

12 December 2020

Androgen receptor signaling regulates DNA repair in prostate cancers

1 reference

12 December 2020

Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer

1 reference

12 December 2020

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

1 reference

12 December 2020

Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.

1 reference

12 December 2020

68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

1 reference

12 December 2020

In vitro and in vivo model systems used in prostate cancer research

1 reference

12 December 2020

Repeated fine-needle aspiration of solid tumours in mice allows the identification of multiple infiltrating immune cell types

1 reference

12 December 2020

Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.

1 reference

12 December 2020

Castration radiosensitizes prostate cancer tissue by impairing DNA double-strand break repair

1 reference

12 December 2020

Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy

1 reference

12 December 2020

Addition of PSMA ADC to enzalutamide therapy significantly improves survival in in vivo model of castration resistant prostate cancer

1 reference

12 December 2020

68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience.

1 reference

12 December 2020

44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617-preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617.

1 reference

12 December 2020

Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling

1 reference

12 December 2020

Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer

1 reference

12 December 2020

Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation.

1 reference

12 December 2020

Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy

1 reference

12 December 2020

Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells

1 reference

12 December 2020

Detection Threshold and Reproducibility of 68Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer

1 reference

12 December 2020

Dosimetry of Lu-177 PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pre-therapeutic imaging and "whole body" tumor dosimetry with treatment outcomes

1 reference

12 December 2020

10.1186/S13550-018-0451-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 May 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30374743%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

PubMed publication ID

30374743

1 reference